US EditionLokavant’s Spectrum turns clinical-trial planning into a live simulation
Summary by Drug Discovery and Development
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Lokavant’s Spectrum turns clinical-trial planning into a live simulation
The clinical-trial intelligence company Lokavant has debuted Spectrum, an AI-powered tool that crunches weeks of feasibility work down to minutes. Pfizer, an early adopter, now refreshes enrollment and timeline projections almost in real time. “Instead of it being five weeks to five minutes, essentially it’s a simulation every five minutes,” said Jonathan Crowther, Pfizer’s head… The post Lokavant’s Spectrum turns clinical-trial planning into a …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
